Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continuing their series celebrating ‘amazing people at Oxford who you should know about’, The Oxford ScienceBlog talks to Dayne Beccano-Kelly, an electrophysiologist and a Career Development Fellow in Oxford Parkinson’s Disease Centre, in the Department of Physiology, Anatomy and Genetics.

Image of Dayne Beccano-Kelly

With more than ten years’ experience in the field, Dayne discusses his research using human neurones to improve treatments and the quality of life for people with neurodegenerative conditions such as Parkinson’s disease. He also shares how he is aiming to tackle the lack of BAME leadership opportunities in STEM, by mentoring and inspiring black and minority ethnic scientists of tomorrow.

How would you describe your journey to Oxford?

I am from Cardiff originally, and took my undergraduate degree at Leeds University in bio-chemistry, as a route into medicine. But, after my first year, I changed my mind with a stint in research, as part of my year in industry.

Time and experience showed me that what I really wanted to do was science research, helping people, but being the one to garner the knowledge that would help. It is fun to be continually asking the questions, and driving the conversation on known scientific knowledge.

Was Oxford what you expected it to be?

Oxford is a melting pot of scientific ideas that are often brewing a stone’s throw away, which makes it easier to interact with other scientists and develop collaborations.

I have been here four years now and don’t feel marginalised at Oxford. I expected there to be a low number of BAME academics at Oxford, because there have been at every other institution.

Having lived in Vancouver directly before this, which I loved in a different way, I can feel the contrast. It’s great to be surrounded by so much history. Vancouver is younger than Arsenal FC, my football team.

Read the full interview (Oxford Science Blog)

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.